Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer

NCT04897009 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Invasive Breast Carcinoma

Interventions

PROCEDURE: Biospecimen Collection

Sponsor

Mayo Clinic

Collaborators

[object Object]